Top Markets
Coin of the day
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Clasificación en acciones #118
Abbott Laboratories, along with its affiliated entities, is a global healthcare... Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
Precio por acción
$97.46
Última sincronización: 2026-10-02
Capitalización bursátil
$168.63B
Cambio (1 día)
0.77%
Cambio (1 año)
-27.59%
País
US
Comercio Abbott Laboratories (ABT)

Categoría

Margen Operativo de Abbott Laboratories (ABT)
Margen Operativo al October 2026 TTM: 17.03%
Según los informes financieros más recientes y el precio de las acciones de Abbott Laboratories, el margen operativo actual (TTM) es 17.03%. Al final de 2024, el margen operativo era 16.27%.
Historial de Margen Operativo de Abbott Laboratories desde 2000 hasta 2026
Margen Operativo al final de cada año
Año Margen Operativo Cambiar
2026 (TTM) 17.03% -6.22%
2025 18.16% 11.62%
2024 16.27% 1.43%
2023 16.04% -16.28%
2022 19.16% -10.30%
2021 21.36% 39.70%
2020 15.29% 6.25%
2019 14.39% 14.48%
2018 12.57% 74.58%
2017 7.20% -53.79%
2016 15.58% 7.82%
2015 14.45% 0.35%
2014 14.40% 46.64%
2013 9.82% 95.23%
2012 5.03% -71.44%
2011 17.61% -12.17%
2010 20.05% -6.13%
2009 21.36% 3.59%
2008 20.62% 8.07%
2007 19.08% -1.09%
2006 19.29% -7.30%
2005 20.81% -1.98%
2004 21.23% 40.50%
2003 15.11% -15.21%
2002 17.82% 53.22%
2001 11.63% -52.99%
2000 24.74% 0.00%
Margen Operativo de empresas similares o competidoras
Empresa Margen Operativo Diferencia de Margen Operativo País
17.86% -98.95%
IE
22.03% -98.71%
US
21.46% -98.74%
US
0.00% -
DE
28.09% -98.35%
US
¿Qué es el Margen Operativo de una empresa?
El Margen Operativo es un indicador clave para evaluar la rentabilidad de una empresa. Un margen operativo más alto suele ser mejor, ya que indica que una empresa puede vender sus productos o servicios por mucho más de lo que cuestan producirlos. Se calcula dividiendo las ganancias de la empresa entre sus ingresos.